DIAGNOS announces a 3-year partnership agreement with the University of Montreal Hospital Centre (CHUM) on the use of Artificial Intelligence

    NEXT STORY
    Lixte Biotechnology and City of Hope to Initiate Phase 1b Clinical Trial of Lixte’s Lead Compound LB-100 to Treat Small Cell Lung Cancer
    PREV STORY
    Novan Provides Enrollment Update and Announces New Corporate Headquarters
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche partners with Moderna to include SARS-CoV-2 antibody test in ongoing COVID-19 vaccine trials

    author_avatar
    NASDAQ Market News

    Aduro Biotech Presents Preclinical Data Supporting Clinical Development of its Anti-APRIL Antibody, BION-1301, for the Treatment of Multiple Myeloma

    BERKELEY, Calif. and OSS, The Netherlands, Dec. 03, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, ...

    author_avatar
    NASDAQ Market News

    Developing vaccines and therapies for the highly pathogenic Nipah and Hendra viruses

    author_avatar
    NASDAQ Market News